Novel Amine Derivative Inhibits TNF-Alpha for Psoriasis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic methods for skin diseases associated with keratinocyte proliferation, such as psoriasis, are unsatisfactory and often come with side effects like skin atrophy, necessitating the development of more effective drugs that can inhibit keratinocyte proliferation and TNFα production.
Innovation Solution
A novel compound represented by a specific general formula or its salts, which inhibits keratinocyte proliferation and TNFα production, is used to treat skin diseases like psoriasis, skin cancer, and chronic wounds, offering improved safety and pharmacokinetics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If steroid formulations are used to treat psoriasis and inhibit inflammation, then therapeutic effectiveness is improved, but skin atrophy and skin thinning occur as side effects
Solution Approach 1:
The patent changes the therapeutic parameter from steroid-based anti-inflammatory treatment to a small molecule compound (Formula 1) that selectively inhibits TNF-α production. This parameter change allows achieving anti-inflammatory effects without the harmful side effects of steroids, specifically avoiding skin atrophy and thinning while maintaining therapeutic effectiveness for psoriasis and other keratinocyte proliferation diseases
2Adaptability or versatility
If existing therapeutic methods target molecules involved in cell proliferation, then treatment for skin diseases is provided, but the therapeutic effect is unsatisfactory
Solution Approach 1:
The patent introduces TNF-α as a specific intermediary target in the keratinocyte proliferation pathway. By developing Compound (1) that selectively inhibits TNF-α production, the invention achieves a more effective and specific therapeutic approach compared to existing methods that target broader cell proliferation mechanisms, thereby improving both the precision and effectiveness of treatment
Data Source
AI summary
A novel amine derivative expressed by general formula (1) (in the formula: G1, G2, and G3 are the same or different and represent CH or a nitrogen atom; R1 represents a chlorine atom, an optionally-substituted C3-8 cycloalkyl group, or the like; R2 represents -COOR5 (in the formula, R5 represents a hydrogen atom or a carboxyl protective group), or the like; R3 represents a hydrogen atom, or the like; and R4 represents an optionally-substituted condensed bicyclic hydrocarbon group, an optionally-substituted bicyclic heterocyclic group, or the like), or a salt thereof is useful in procedures such as the treatment or prevention of conditions related to excessive keratinocyte proliferation.